SCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation

Gynecologic and Obstetric Investigation

Volumn 64, Issue 1, 2007, Pages 8-13

  Laskowska, Marzena ^a   Laskowska, Katarzyna ^a   Leszczyńska Gorzelak, Bozena ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CD40L; Intrauterine growth retardation; Maternal and umbilical serum; Pre eclampsia

Indexed keywords

CD40 LIGAND; CYTOKINE; FAS LIGAND;

ADULT; ANALYTIC METHOD; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD40 LIGAND; COHORT STUDIES; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 34347361624     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098316     Document Type: Article

References (30)

1. Vogel LA, Noelle RJ: CD40 and its role as a member of TNFR family. Semin Immunol 1998;10:435-442.
2. Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992;1149:775-782.
3. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995;182:33-40.
4. Stout RD, Suttles J: The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996;17:487-492.
5. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ: The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2597-2510.
6. Gauchat JF, Henchoz S, Fattah D, Mazzei G, Aubry JP, Jomotte T, et al: CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995;25:863-865.
7. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, et al: Induction of human Ig E synthesis in B cells by mast cells and basophils. Nature 1993;365:340-343.
8. Henn V, Slupsky JR, Grafe M, Aagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594.
9. Younes A, Snell V, Consoli U, Clodi K, Zhao S, Palmer JT, et al: Elevated levels of biologically active CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br J Haematol 1998;100:135-141.
10. Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK: Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 1999;42:871-881.
11. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ: Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs.-host disease. J Clin Invest 1994;94:200-203.
12. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, et al: CTLA4Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997;94:8789-8794.
13. Hsu ChD, Harirah H, Basherra H, Mor AG: Serum soluble Fas Levels in preeclampsia. Obstet Gynecol 2001;97:530-532.
14. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger ChM, Asa SL: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997;82:3173-3175.
15. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C: Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003;52:1435-1441.
16. Inwalid DP, McDowall A, Peters MJ, Callard RE, Klein NJ: CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circulation Res 2003;92:1041-1048.
17. Freedman JE: CD40-CD40L and platelet function: beyond hemostasis. Circulation Res 2003;92:944-946.
18. Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
19. Khong TY, Mott Ch: Immunohistologic demonstration of endothelial disruption in acute atherosis in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1993;51:193-197.
20. Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J: Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006;107:896-900.
21. Chauhan SP, Cole J, Sanderson M, Magann EF, Scardo JA: Suspicion of intrauterine growth restriction: use of abdominal circumference alone or estimated fetal weight below 10%. J Matern Fetal Neonatal Med 2006;19:557-562.
22. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P: Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia-possible role of platelet activation. Thromb Haemost 2001;86:1272-1276.
23. Kelly RW, King AE, Critchley HOD: Inflammatory mediators and endometrial function-focus on the perivascular cell. J Reprod Immunol 2002;57:81-93.
24. Phipps RP: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000;97:6930-6932.
25. Andre P, Nannizzi-Alaimo L, Prasad SK, Philips DR: Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002;106:896-899.
26. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, et al: CD40L stabilizes arterial thrombi by an A3 integrin-dependent mechanism. Nat Med 2002;8:247-252.
27. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G: Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998;80:1008-1014.
28. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, et al: Activated T cells induce interleukin-12 productions by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125.
29. Tian L, Noelle RJ, Lawrence DA: Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995;25:306.
30. Laskowska M, Vinson GP, Szumiło J, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J: Comparative analysis of the angiotensin II receptor in placental vascular endothelial cells in preeclamptic and normotensive patients. Gynecol Obstet Invest 2003;56:55-60.